Windtree Therapeutics to Host Virtual R&D and Investor Day Focusing on the Cardiogenic Shock Market, Istaroxime, Company Strategy and Planned Near-Term Milestones
Virtual event to take place on June 14, 2023 at 1:00 pm ET WARRINGTON, Pa.,…
Virtual event to take place on June 14, 2023 at 1:00 pm ET WARRINGTON, Pa.,…
Virtual event to take place on June 14, 2023 at 1:00 pm ET WARRINGTON, Pa.,…
– No dose limiting toxicities observed with IMM-1-104 up to 320 mg once daily during…
– No dose limiting toxicities observed with IMM-1-104 up to 320 mg once daily during…
LYON, France and CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Amolyt Pharma, a global…
LYON, France and CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Amolyt Pharma, a global…
SANTA ANA, Calif., June 05, 2023 (GLOBE NEWSWIRE) — NKGen Biotech Inc. (NKGen), a clinical-stage…
SANTA ANA, Calif., June 05, 2023 (GLOBE NEWSWIRE) — NKGen Biotech Inc. (NKGen), a clinical-stage…
PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE) — Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company…
PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE) — Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company…
– Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis…
– Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis…
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell…
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell…
ADELAIDE, Australia, June 05, 2023 (GLOBE NEWSWIRE) — Carina Biotech (Carina), a cell therapy immuno-oncology…
ADELAIDE, Australia, June 05, 2023 (GLOBE NEWSWIRE) — Carina Biotech (Carina), a cell therapy immuno-oncology…
100% of treated patients (n=8) to date have exceeded historical median progression-free survival, with two…
100% of treated patients (n=8) to date have exceeded historical median progression-free survival, with two…
NEEDHAM, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company)…
NEEDHAM, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company)…